NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,090.003 days ago
1,148.803 days ago
arrow

LOWER/UPPER CIRCUITS

894.80
1,342.00
arrow
Jubilant Pharmova Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : -3.03%
Net profit growth 5Y CAGR : -39.03%
Jubilant Pharmova Ltd Top mutual funds holding
arrow
Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses. With a solid network of radio-pharmacies in the US, Jubilant’s Radiopharma business is engaged in manufacturing and supply of Radiopharmaceutical products and services. Its other businesses such as Allergy Immunotherapy, Contract Manufacturing of Sterile Injectables and Non-sterile products and Generics (Solid Dosage Formulations) caters to major regulated markets (USA, EU and other geographies) through five manufacturing facilities. The CRDMO segment (through Jubilant Biosys) provides collaborative research and partnership for Drug Discovery through two world class research centers in India. The company is also involved in the manufacturing of Active Pharmaceutical Products (API) through a US FDA approved facility in Nanjangud, Karnataka.
personal

Grow your wealth with more research recommendations

+91